Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis identification in patients with pulmonary tuberculosis Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021
Comparison of 3D-CT and fiberoptic bronchoscopy in evaluation of endobronchial tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004
Initial assessment of endobronchial ultra-sound (EBUS) for evaluating broncho-pulmonary lesions in topical anesthesia Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001
Bronchoscopic characteristics of endobronchial tuberculosis Source: Annual Congress 2009 - Interventional pneumology Year: 2009
Factors relevant to bronchostenosis after treatment of endobronchial tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005
Unexpected diagnosis of pulmonary tuberculosis during bronchoscopy using radial probe endobronchial ultrasound Source: Virtual Congress 2021 – Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound Year: 2021
The choice of 4th drug in treatment of cavitary smear positive pulmonary tuberculosis: streptomycine versus ethambutol Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005
Experience in flexible bronchoscopy in childhood endobronchial tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 402s Year: 2007
Ultrasound diagnostics of exudative plurisy among patients with pulmonary tuberculosis with drug resistance Source: Eur Respir J 2004; 24: Suppl. 48, 427s Year: 2004
The efficacy, safety and feasibility of inhaled amikacin for the treatment of refractory non-tuberculous mycobacterial lung diseases Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
The improvement of bacteriological diagnosis through bronchoscopic methods in pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
Clinical and bronchoscopic features in endobronchial tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 23s Year: 2006
Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012
Endobronchial tuberculosis: clinical and bronchoscopic features Source: Eur Respir J 2006; 28: Suppl. 50, 27s Year: 2006
Efficacy of transbronchial biopsies in diagnostics of smear-negative pulmonary TB Source: Annual Congress 2012 - The different ways to establish a diagnosis: needle and forcep Year: 2012
The clinical value of intravenous pulse therapy in first retreatment pulmonary tuberculosis patients Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009
Treatment of severe Mycobacterium avium complex pulmonary disease with a adjunctive amikacin and clofazimine versus standard regimen alone, a retrospective study Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I Year: 2019
Efficiency of intravenous treatment with levofloxacin in patients with MDR pulmonary tuberculosis in the intensive phase of chemotherapy Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021